Insights

Loading spinner
Gathering insights about Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc. Tech Stack

Satsuma Pharmaceuticals, Inc. uses 8 technology products and services including LiveIntent, RSS, Salesforce, and more. Explore Satsuma Pharmaceuticals, Inc.'s tech stack below.

  • LiveIntent
    Advertising
  • RSS
    Content Management System
  • Salesforce
    Customer Relationship Management
  • RequireJS
    Javascript Frameworks
  • Yoast SEO
    Search Engines
  • Piwik
    System Analytics & Monitoring
  • Google Tag Manager
    Tag Management
  • TouchSwipe
    Web Tools And Plugins

Media & News

Satsuma Pharmaceuticals, Inc.'s Email Address Formats

Satsuma Pharmaceuticals, Inc. uses at least 1 format(s):
Satsuma Pharmaceuticals, Inc. Email FormatsExamplePercentage
F.Last@satsumarx.comJ.Doe@satsumarx.com
57%
First@satsumarx.comJohn@satsumarx.com
30%
First.Last@satsumarx.comJohn.Doe@satsumarx.com
7%
FirstLast@satsumarx.comJohnDoe@satsumarx.com
6%

Frequently Asked Questions

Where is Satsuma Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Satsuma Pharmaceuticals, Inc.'s main headquarters is located at 395 Oyster Point Boulevard, Suite 300. The company has employees across 2 continents, including North AmericaAsia.

What is Satsuma Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Satsuma Pharmaceuticals, Inc.'s official website is satsumarx.com and has social profiles on LinkedIn.

What is Satsuma Pharmaceuticals, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Satsuma Pharmaceuticals, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Satsuma Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Satsuma Pharmaceuticals, Inc. has approximately 27 employees across 2 continents, including North AmericaAsia. Key team members include Vice President And Head Of Manufacturing: D. P.Vice President And Head Of Operations: M. I.Vice President & Head Of Regulatory Affairs: J. C.. Explore Satsuma Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Satsuma Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
Satsuma Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Satsuma Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
Satsuma Pharmaceuticals, Inc.'s tech stack includes LiveIntentRSSSalesforceRequireJSYoast SEOPiwikGoogle Tag ManagerTouchSwipe.

What is Satsuma Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
Satsuma Pharmaceuticals, Inc.'s email format typically follows the pattern of F.Last@satsumarx.com. Find more Satsuma Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has Satsuma Pharmaceuticals, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Satsuma Pharmaceuticals, Inc. has raised $153M in funding. The last funding round occurred on Sep 01, 2020 for $91M.

When was Satsuma Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
Satsuma Pharmaceuticals, Inc. was founded in 2016.

Satsuma Pharmaceuticals, Inc.

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

We are a clinical-stage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other debilitating conditions. Our initial product candidate is STS101 (dihydroergotamine (DHE) nasal powder), which we are focused on developing as an important and differentiated therapeutic option for the acute treatment of migraine

Section iconCompany Overview

Headquarters
395 Oyster Point Boulevard, Suite 300
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $153M

    Satsuma Pharmaceuticals, Inc. has raised a total of $153M of funding over 2 rounds. Their latest funding round was raised on Sep 01, 2020 in the amount of $91Mas a initial public offering.

  • $25M$50M

    Satsuma Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $153M

    Satsuma Pharmaceuticals, Inc. has raised a total of $153M of funding over 2 rounds. Their latest funding round was raised on Sep 01, 2020 in the amount of $91Mas a initial public offering.

  • $25M$50M

    Satsuma Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.